A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients

por Absenger, G, Szkandera, J, Pichler, M, Stotz, M, Arminger, F, Weissmueller, M, Schaberl-Moser, R, Samonigg, H, Stojakovic, T, Gerger, A
Publicado 2013